Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease

Corticosteroid refractory graft-versus-host disease (GVHD) is one of the major challenges in the management of allogeneic stem cell transplant recipients. Although numerous agents have been employed to treat this patient population, no standardized second-line therapy exists. In this study, we repor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Drobyski, William R., Pasquini, Marcelo, Kovatovic, Kathy, Palmer, Jeanne, Rizzo, J. Douglas, Saad, Ayman, Saber, Wael, Hari, Parameswaran
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3716013/
https://ncbi.nlm.nih.gov/pubmed/21745454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2011.07.001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares